Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Cetuximab and irinotecan/5-fluorouracil/folinic acid is a safe combination for the first-line treatment of patients with epidermal growth factor receptor expressing metastatic colorectal carcinoma

Cetuximab and irinotecan/5-fluorouracil/folinic acid is a safe combination for the first-line... http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Annals of Oncology Unpaywall

Cetuximab and irinotecan/5-fluorouracil/folinic acid is a safe combination for the first-line treatment of patients with epidermal growth factor receptor expressing metastatic colorectal carcinoma

Loading next page...
 
/lp/unpaywall/cetuximab-and-irinotecan-5-fluorouracil-folinic-acid-is-a-safe-UBOmmzSFSy

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Unpaywall
ISSN
0923-7534
DOI
10.1093/annonc/mdj084
Publisher site
See Article on Publisher Site

Abstract

Journal

Annals of OncologyUnpaywall

Published: Mar 1, 2006

There are no references for this article.